TLRY Stock Analysis: Buy, Sell, or Hold?
TLRY - Tilray Brands, Inc. Common Stock
$4.47
-0.01 (-0.22%)
âŧ
5d:
-6.49%
30d:
+5.67%
90d:
-13.71%
WAIT
LOW Confidence
Analysis Updated: Aug 18, 2026 12:00 AM ET
Earnings: Oct 08, 2026
Smart Money Accumulation
Options open interest is building while the stock consolidates - a pattern consistent with institutional accumulation. View Scanner →
Signal fired Aug 14, 2026 at $4.58 · last confirmed Aug 14, 2026
Strength: 5.9/10
Get Alerted When TLRY Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
âšī¸ NEUTRAL: TLRY is fairly priced but lacks strong directional signals. At 0% expected growth, valuation appears cheap. Wait for clearer setup or better entry on dips.
âšī¸ NEUTRAL: TLRY is fairly priced but lacks strong directional signals. At 0% expected growth, valuation appears cheap. Wait for clearer setup or better entry on dips.
In-depth Analysis How we analyze
Valuation Analysis: TLRY is currently trading at $4.47, which is considered fair relative to its 30-day fair value range of $4.14 to $4.61. From a valuation perspective, the stock is trading at a discount (Forward PE: -11.4) compared to its historical average (201.6). At these levels, the market is pricing in 0% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.
Technical Outlook: Technically, TLRY is in a strong downtrend. Immediate support is located at $4.33, while resistance sits at $4.83.
Market Sentiment: TLRY scores 33/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $7.84 (+75.5%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, TLRY is in a strong downtrend. Immediate support is located at $4.33, while resistance sits at $4.83.
Market Sentiment: TLRY scores 33/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $7.84 (+75.5%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
FAIR
Historical Trading Range
$4.14 -
$4.61
Company Quality Score
52/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
54.8%
Protect Your Profits
Holding TLRY? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- NEUTRAL: Price in fair range
- BEARISH: Weak technical setup (33/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 75.5% below Wall St target ($7.84)
- BULLISH: Market expects only 0% annual growth - appears undervalued
- WARNING: Composite score 52/100 in the bottom quintile â this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$4.14 -
$4.61
Current vs Trading Range
FAIR
Support & Resistance Levels
Support Level
$4.33
Resistance Level
$4.83
Current Trend
Strong Downtrend
Technical data as of
Aug 18, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-11.42
Wall Street Target
$7.84
(+75.5%)
Revenue Growth (YoY)
-7.8%
Profit Margin
-13.3%
PE vs Historical
-11.4 vs 201.6
CHEAP
Share & Embed Analysis
Last updated: August 18, 2026 5:41 PM ET
Data refreshes hourly during market hours. Next update: 6:41 PM
Data refreshes hourly during market hours. Next update: 6:41 PM
đĨ Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is TLRY showing a specific setup today?
Insider Activity (6 Months)
0
Buys
1
Sells
Net
INSIDERS SELLING
Recent Transactions
David G Hopkinson
SELL
33556 shares
2026-04-21
Top Rated Drug Manufacturers - Specialty & Generic Stocks
Top-rated stocks in Drug Manufacturers - Specialty & Generic by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
NBIX
Neurocrine Biosciences IâĻ |
STRONG BUY
25 analysts |
$212 | 67 BUY |
|
UTHR
United Therapeutics CorpâĻ |
STRONG BUY
15 analysts |
$653 | 61 BUY |
|
LNTH
Lantheus Holdings Inc |
STRONG BUY
13 analysts |
$107 | 56 HOLD |
|
ZTS
Zoetis Inc |
BUY
20 analysts |
$101 | 49 HOLD |
|
ALKS
Alkermes Plc |
BUY
15 analysts |
$56 | 68 BUY |
Advanced TLRY Option Strategies
Professional options setups generated by AI based on today's TLRY price and gamma walls.
